What is the prevalence of Rothmund-Thomson Syndrome?

Rothmund-Thomson Syndrome (RTS) is an ultra-rare genetic disorder with an estimated prevalence of less than 1 in 1,000,000 individuals worldwide. While exact figures are difficult to determine due to significant underdiagnosis and phenotypic variability, fewer than 300 cases have been documented in clinical literature to date.

How rare is Rothmund-Thomson Syndrome?

Rothmund-Thomson Syndrome is classified as an ultra-rare condition. Because the clinical presentation can overlap with other genodermatoses, it is likely that many cases remain undiagnosed or misattributed. The true prevalence of Rothmund-Thomson Syndrome is unknown, but it is considered extremely uncommon in the general population across all geographic regions and ethnic groups.

What is the demographic distribution of Rothmund-Thomson Syndrome?

Rothmund-Thomson Syndrome affects both males and females equally, with no reported predilection for specific populations. The condition is typically diagnosed in early childhood, often appearing within the first six months of life when characteristic skin changes, known as poikiloderma, begin to manifest. While Rothmund-Thomson Syndrome is primarily identified in pediatric patients, it is a lifelong condition that requires ongoing medical surveillance into adulthood.

Why is accurate data for Rothmund-Thomson Syndrome limited?

Estimating the frequency of Rothmund-Thomson Syndrome is challenging for several reasons:

• Clinical Heterogeneity: Symptoms vary widely between individuals, leading to diagnostic delays.


• Underdiagnosis: Milder cases may not come to clinical attention.


• Genetic Complexity: Mutations in the RECQL4 gene are responsible for many cases, but not all patients with a clinical diagnosis of Rothmund-Thomson Syndrome test positive for known mutations.

How does the DiseaseMaps community reflect these challenges?

Real-world data, such as that found on DiseaseMaps.org, highlights the isolation often felt by those living with ultra-rare conditions. Currently, 2 individuals have joined the DiseaseMaps community to share their experiences with Rothmund-Thomson Syndrome. These community-led insights provide a vital, human-centered perspective that complements the sparse statistical data available in medical literature.

Next steps

• Consult a clinical geneticist to discuss molecular testing if you suspect a diagnosis of Rothmund-Thomson Syndrome.


• Connect with the DiseaseMaps.org community to share experiences and find peer support.


• Seek specialized care from dermatologists and oncologists familiar with the surveillance protocols required for this syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare professional regarding any medical condition.

References

• Orphanet: Rothmund-Thomson Syndrome (ORPHA:793)


• NIH Genetic and Rare Diseases Information Center (GARD): Rothmund-Thomson Syndrome


• OMIM (Online Mendelian Inheritance in Man): #268400


• GeneReviews: RECQL4-Related Disorders